ZACKS RESEARCH

FUNDS

PORTFOLIO

BROKER RESEARCH

MARKETS

SCREENING

EDUCATION

SERVICES

Earnings

EPS Surprises

Mutual Funds

Options

My Account

Help

Top Stocks Set to Outperform
Over the Next 1 to 3 Months.
Click for your free picks >>

Quote:

Search for Ticker

Free Membership

Search:

MDRX: Allscripts Misys Healthcare Solu - Full Company Report Enter Ticker:

Quote	Estimates	Charts	Company Reports	News	Financials

Full Company Report \| Estimates \| Brokerage Recommendations \| Comparison to Industry \| Insiders \| Brokerage Reports \| Zacks Equity Research \| Annual Report

ALLSCRIPTS MISYS HEALTHCARE SOLU (NASD)
MDRX	20.45	0.38	(1.89%)	Vol. 700,133	16:00 ET

ALLSCRIPTS-MISYS HEALTHCARE SOLUTIONS, INC., formerly Allscripts Healthcare Solutions, Inc., is a provider of clinical software, connectivity and information solutions that are used by the physicians. The Company's businesses provide solutions that inform physicians with just in time information, and connect physicians to each other and to the entire community of care. The Company operates through three business segments: software and related services, information services and prepackaged medications.

General Information

ALLSCRIPTS-MISY

222 Merchandise Mart Plaza Suite 2024 Chicago, IL 60654 Phone: 866 358-6869 Fax: 312 506-1201 Web: www.allscripts.com Email: investor.relations@allscripts.com

Industry	MEDICAL INFO SYS
Sector:	Medical

Fiscal Year End	May
Last Reported Quarter	08/31/09
Next EPS Date	01/07/2010

Price and Volume Information

Zacks Rank
Yesterday's Close	20.07
52 Week High	22.21
52 Week Low	6.21
Beta	1.29
20 Day Moving Average	725,047.00
Target Price Consensus	20.27

% Price Change
4 Week	-5.55
12 Week	29.82
YTD	102.32

% Price Change Relative to S&P 500
4 Week	-6.57
12 Week	22.39
YTD	67.44

Share Information
Shares Outstanding (millions)	145.13
Market Capitalization (millions)	2,912.80
Short Ratio	4.72
Last Split Date	N/A

Dividend Information
Dividend Yield	0.00%
Annual Dividend	$0.00
Payout Ratio	0.00
Change in Payout Ratio	0.00
Last Dividend Payout / Amount	NA / $0.00

EPS Information
Current Quarter EPS Consensus Estimate	0.13
Current Year EPS Consensus Estimate	0.55
Estimated Long-Term EPS Growth Rate	19.50
Next EPS Report Date	01/07/2010

Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)	2.45
30 Days Ago	2.38
60 Days Ago	2.37
90 Days Ago	2.37

Fundamental Ratios

P/E
Current FY Estimate:	36.41
Trailing 12 Months:	35.84
PEG Ratio	1.87

EPS Growth
vs. Previous Year	0.00%
vs. Previous Quarter	-13.33%

Sales Growth
vs. Previous Year	92.42%
vs. Previous Quarter:	-0.78%

Price Ratios
Price/Book	3.87
Price/Cash Flow	31.33
Price / Sales	4.70

ROE
08/31/09	11.14
05/31/09	10.87
02/28/09	9.72

ROA
08/31/09	8.22
05/31/09	7.69
02/28/09	6.58

Current Ratio
08/31/09	1.74
05/31/09	1.59
02/28/09	1.66

Quick Ratio
08/31/09	1.72
05/31/09	1.57
02/28/09	1.63

Operating Margin
08/31/09	12.85
05/31/09	12.42
02/28/09	11.26

Net Margin
08/31/09	-
05/31/09	8.09
02/28/09	3.51

Pre-Tax Margin
08/31/09	-
05/31/09	8.09
02/28/09	3.51

Book Value
08/31/09	5.18
05/31/09	4.91
02/28/09	4.92

Inventory Turnover
08/31/09	-
05/31/09	51.10
02/28/09	36.28

Debt-to-Equity
08/31/09	0.05
05/31/09	0.09
02/28/09	0.09

Debt to Capital
08/31/09	5.14
05/31/09	8.34
02/28/09	8.48


About Zacks \| Advertise \| Media \| Careers \| Contact Us \| Help Disclaimer \| Privacy Policy \| Sitemap NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. Copyright 2009 Zacks Investment Research